Discover 3,507 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,507
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
for
Open Angle Glaucoma (OAG),
Location: Glendale CA, Charleston SC, New York NY, Boston MA
Sponsor: Life Biosciences Inc.
Sex: All
Age: 40 - 70+
Code: NCT07290244
Phase 1, Recruiting
Final Prototype Refinement of Adaptive Cell Phone Support
for
Medication Adherence
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles
Sex: All
Age: 15 - 20
Code: NCT07084155
Recruiting
Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT07306338
Recruiting
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
for
Sepsis, Acute Kidney Injury
Location: Newport Beach CA, Kansas City KS, Detroit MI,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07215702
Phase 2, Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Los Angeles CA, San Diego CA, San Francisco CA,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT04485559
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
for
Healthy Participants, Hemophilia A, Hemophilia B,
Location: Los Angeles CA, St Louis MO, Metairie LA, Chicago IL,
Sponsor: Equilibra Bioscience LLC
Sex: All
Age: 18 - 60
Code: NCT06349473
Phase 1, Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Location: Irvine CA, Tucson AZ, Nampa ID, Meridian ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04840602
Phase 2, Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
for
Hepatocellular Carcinoma (HCC)
Location: Duarte CA, Portland OR, Nashville TN, Hackensack NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07291076
Phase 1, Phase 2, Recruiting
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
for
Relapsing Remitting Multiple Sclerosis
Location: Irvine CA, Seattle WA, Austin TX, Houston TX,
Sponsor: SetPoint Medical Corporation
Sex: All
Age: 22 - 60
Code: NCT06796504
Recruiting
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
for
Adenovirus, Primary Immune Deficiency Disorder
Location: Los Angeles CA, San Francisco CA, Aurora CO,
Sponsor: New York Medical College
Sex: All
Age: 0 - 70+
Code: NCT03266627
Phase 2, Recruiting
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC